VS
Compare Evolve Global Healthcare Enhanced Yield ETF (LIFE) vs Harvest Healthcare Leaders Income ETF (HHL) to find the best fit for your portfolio. LIFE provides Healthcare exposures, while HHL is primarily weighted in Healthcare and Sovereign. When evaluating costs, LIFE features a management fee (MER) of 0.45%, compared to 0.85% for HHL. Performance-wise, LIFE has returned 0.49% year-to-date with +$32 M in net flows, whereas HHL is at 0.42% with +$362 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
LIFE
HHL
| AuM | $268.86 M | $1,854.43 M |
| Management Fees | 0.45% | 0.85% |
| Exp. ratio | 0.65% | 0.98% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 15, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | LIFE | -1.16% | +6.81% | -0.49% | +10.12% | +0.86% |
HHL | -2.01% | +7.33% | +0.42% | +11.61% | +19.91% | |
| Flows | LIFE | +$5 M | +$8 M | +$32 M | +$63 M | +$104 M |
HHL | +$9 M | +$48 M | +$362 M | +$364 M | +$693 M |
LIFE vs HHL exposure
Countries
LIFE
USA
71.44%
Switzerland
10.09%
United Kingdom
9.46%
Other
9.02%
HHL
USA
84.21%
Other
15.79%
Sectors
LIFE
Healthcare
101.04%
HHL
Healthcare
98.89%
As of September 15, 2026
Top 10 Holdings
LIFE
Bristol Myers Squibb Co.
5.65%
Thermo Fisher Scientific, Inc.
5.63%
Abbott Laboratories
5.53%
Amgen, Inc.
5.29%
Stryker Corp.
5.22%
Medtronic Plc
5.21%
Pfizer Inc.
5.19%
Roche Holding AG
5.18%
Merck & Co., Inc.
5.08%
Gilead Sciences, Inc.
5.07%
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
Diversification
LIFE
Total weight of top 10 holdings out of 20 total
53.06%
HHL
Total weight of top 10 holdings out of 25 total
50.34%
Characteristics
Compare
LIFE
HHL
| Provider | Evolve ETFs | Harvest Portfolios Group |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 11.86% | 9.95% |
| Meets ESG criteria | No | No |
| Inception Date | October 25, 2017 | December 18, 2014 |
Frequently asked questions about LIFE and HHL
Which ETF has performed better year to date: LIFE or HHL?
As of September 15, 2026, LIFE has returned -0.49% year to date, while HHL has returned 0.42%. HHL is ahead on YTD performance.
Which ETF is larger by assets under management: LIFE or HHL?
As of September 15, 2026, LIFE manages $268.86 M in assets, while HHL manages $1.85 B. HHL is the larger fund by AUM.
How are LIFE and HHL managed?
LIFE is actively managed by Evolve ETFs. It does not track an index. HHL is actively managed by Harvest Portfolios Group. It does not track an index.
What sectors do LIFE and HHL emphasize?
LIFE is most exposed to Healthcare. HHL is most exposed to Healthcare and Sovereign.
Which ETF is attracting more investor flows: LIFE or HHL?
Year to date, LIFE has seen +$32.11 M in net flows, compared with +$361.73 M for HHL. HHL has attracted more net investor money so far.
How do the fees of LIFE and HHL compare?
LIFE has an expense ratio of 0.65%, while HHL has an expense ratio of 0.98%.
What are the top holdings of LIFE and HHL?
LIFE's largest holdings include Bristol Myers Squibb Co., Thermo Fisher Scientific, Inc., and Abbott Laboratories. HHL's top holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co..
Which ETF is more diversified: LIFE or HHL?
LIFE holds 20 securities, while HHL holds 25. On holdings count, HHL is the more diversified portfolio.
Recent articles about LIFE and HHL
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.